#humanmicrobiome

[drritamarie]

What is the Microbiome?

Perhaps the most well-known role of the human gut flora is digestion. Gut bacteria not only help with the fermentation of fibers and the breakdown of food, but they also produce essential vitamins like vitamin K and many B vitamins. A balanced microbiome is necessary for proper nutrition absorption and digestion.

The gut flora is also crucial for immune function. They function as a barrier against infections, regulate inflammation, and interact with the immune system. Many immune-related disorders, such as autoimmune illnesses, allergies, and inflammatory bowel disease, have been linked to dysbiosis of the microbiome.

#digestivehealth #metabolichealth #Microbiome #GutHealth #HealthyGut #MicrobiomeScience #GutBacteria #Microbiota #Probiotics #DigestiveHealth #MicrobiomeResearch #GutMicrobiome #Wellness #HealthyLiving #GutFlora #HealthScience #MicrobiomeAwareness #MicrobiomeFacts #HumanMicrobiome

[beingsanket]

#humanmicrobiome #igymax #healthyfood #nutrition #diet #energy #healthyimmunesystem #healthymicrobiome #igynutrition #iloveigymax #igystyle #healthy #inflammation #igyhealth #healthygut #gutbrainbalance #healthydigestion #immunization #fitness #nutritionals #igymaxrules #igylife #gutmicrobiome #healthytips #eathealthy #healthymeal #fit #health #thisisigy #igygut

[lucy20kart]

There has been various attempts at understanding the mechanism of this microbiome. Read More@  https://bit.ly/3cvzxXE

#HumanMicrobiome HumanBody Healthcare Health Medical Microbiome HumanHealth Disease humanBody Human Microbiome

[reverendtonezone]

#handcut #humanmicrobiome #roganbrown

[markresearch-blog]

Global Human Microbiome Sales Market - Industry Analysis, Size, Share, Trends, and Forecast Report 2017-2022

Albany, New York, August 14, 2017: Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Global Human Microbiome Sales Market Report 2017” to its report offerings. The report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Human Microbiome for these regions, from 2012 to 2022 (forecast).

Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1289577

The global Human Microbiome market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Human Microbiome for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Human Microbiome market competition by top manufacturers/players, with Human Microbiome sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including Merck DuPont MicroBiome Therapeutics Osel Metabiomics Corporation Enterome Bioscience Yakult ViThera Pharmaceuticals Vedanta BioSciences On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into Prebiotics Medical Foods Drugs Probiotics Food Devices Other Probiotic Supplements On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Human Microbiome for each application, including Diagnostics Therapeutics

Read Full Report with TOC: http://www.marketresearchhub.com/report/global-human-microbiome-sales-market-report-2017-report.html

Table of Contents:

1 Human Microbiome Market Overview 1.1 Product Overview and Scope of Human Microbiome 1.2 Classification of Human Microbiome by Product Category 1.2.1 Global Human Microbiome Market Size (Sales) Comparison by Type (2012-2022) 1.2.2 Global Human Microbiome Market Size (Sales) Market Share by Type (Product Category) in 2016

2 Global Human Microbiome Competition by Players/Suppliers, Type and Application 2.1 Global Human Microbiome Market Competition by Players/Suppliers 2.1.1 Global Human Microbiome Sales and Market Share of Key Players/Suppliers (2012-2017) 2.1.2 Global Human Microbiome Revenue and Share by Players/Suppliers (2012-2017)

3 United States Human Microbiome (Volume, Value and Sales Price) 3.1 United States Human Microbiome Sales and Value (2012-2017) 3.1.1 United States Human Microbiome Sales and Growth Rate (2012-2017) 3.1.2 United States Human Microbiome Revenue and Growth Rate (2012-2017)

4 China Human Microbiome (Volume, Value and Sales Price) 4.1 China Human Microbiome Sales and Value (2012-2017) 4.1.1 China Human Microbiome Sales and Growth Rate (2012-2017) 4.1.2 China Human Microbiome Revenue and Growth Rate (2012-2017)

Make an Enquiry: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1289577

About Market Research Hub:        

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Details:

90 State Street,

Albany, NY 12207,

United States

Toll Free: 866-997-4948 (US-Canada)

Tel: [phone]

Email: [email protected]

Website: http://www.marketresearchhub.com/

Read Industry News: https://www.industrynewsanalysis.com/

#HumanMicrobiome #Medical #Pharmaceutical

[mindisuniverse-blog]

The #NEW Slim is NOW available!! Benefits of the New Slim with a #microbiome formula: 💥 An increase in Lactobacillus by 365 times (as in 36,000% INCREASE...yeah 🙀) 💥 An increase in Bifofidobacterium by 290 times 💥 Increases Butyrate by up to 58% 💥 Increases Propionate by up to 25% 💥 An increase in Akkermansia by 250 times... a gut microbe linked to boosting 💪weight loss and 💪metabolism!🔥🔥🔥 Don't be afraid! *Google #Akkermansia *Google "Is A Hidden Fungus Making You Ill?" *Google the #HumanMicrobiome These critical microbes boost Serotonin production, too! Happy Gut = Happy Mood! ❤ New flavor with hints of lemon, watermelon & raspberry 🍋🍉 ❤ NOW only 5 calories! ❤ Gluten free! ❤ No artificial colors, sweeteners, or flavors! ❤️ 100% vegetarian ❤ Mixes quickly in COLD water! Plexus definitely has their finger on the pulse of what people need. It's science, baby! 🙌🙌🙌 #health #passionate #research #new #bestforyou

#microbiome #akkermansia #bestforyou #new #humanmicrobiome #health #research #passionate

[jessicalgross-blog]

FRIENDS, be watching for YET ANOTHER brand-spanking-NEW PRODUCT that will be released THIS WEEK at Convention and I'll be there to be the first to get my hands on it! Yes, ANOTHER one and I've heard that if you thought the 💫NEW SLIM💫 was amazing, you're going to be BLOWN AWAY by this! 🙀🙀🙀 I can't wait!⠀⠀ ⠀⠀ I'm starting a 💥#VIP💥list of people who want to be informed the MOMENT the #newproduct is announced AND the #NEWSlim becomes #available to the public. If you want on that list please comment below OR MESSAGE ME!!! (If you are a customer/ambassador under somebody else, let them know 😍)⠀⠀ ⠀⠀ 👉🏼Some of you can get it NOW! Just PM me!⠀⠀ Google #Akkermansia ⠀⠀ Google "Is A Hidden Fungus Making You Ill?⠀⠀ Google the #HumanMicrobiome⠀⠀ Yup....#Plexus is the real deal. 💯

#vip💥list #plexus #humanmicrobiome #newproduct #newslim #available #akkermansia

[lauren1229]

Happy Wednesday!! I'm starting a 💥VIP💥 list of people who want to be informed the MOMENT the #NEWSlim becomes available to the public. If you want on that list please comment below OR MESSAGE ME!!! 😍 *must not BE an ambassador OR working w/another ambassador! 👉🏼Some of you can get a full supply mailed to your door NOW! Just PM me! Google #Akkermansia Google "Is A Hidden Fungus Making You ill? Google the #HumanMicrobiome Yes........#Plexus is the real deal.

#humanmicrobiome #akkermansia #plexus #newslim

[healthcare-industry-research]

Global Human Microbiome Research - Increasing Collaborations Create Growth Opportunities | Major Industry Leaders

Rising aging population, increasing incidences of lifestyle diseases, gradual demand for efficient and safe medication with no side effects, and treatment of diseases having a limited success rate are driving the growth of the global Human Microbiome Market. The market is an emerging market with abundant opportunities and is expected to flourish within five to seven years owing to a number of products currently under the clinical trial phase. In this report, the global market is divided into three major segments namely, application, disease, and product.

Restraints:

Lack of Expertise and Detailed Research

Barriers in Proving the Causal Link Between Dysbiosis and Disease

Opportunities:

Investigational New Drug (IND) Requirements for Fecal Microbiota

Increasing Collaborations Create Growth Opportunities

Challenge:

Government Regulations

Burning Issues:

Abundant Opportunities in the Human Microbiome Field and Tremendous Research Investments

Development of Human Microbiome Therapeutic Products

Read Some Interesting Facts About "Human Microbiome Research - Global Industry Forecasts to 2025", Here; 

Download PDF Brochure@ http://bit.ly/2sYazsd

Global Industry Segmentation

On the basis of disease, the human microbiome market comprises of obesity, diabetes, autoimmune disorders, acute diarrhea, cancer, mental disorders, and other diseases. In 2022, the acute diarrhea segment is expected to account for the largest share and is estimated to grow at the highest CAGR during the forecast period (2022–2025).

On the basis of product, the human microbiome research spending market is characterized into instruments and consumables. The instruments segment is further divided into laboratory instruments and analyzers, while, the consumables segment is further bifurcated into kits and reagents. The consumables segment is estimated to grow at the highest CAGR during the forecast period (2016–2021) owing to the repeated purchases of consumables as compared to instruments.

On the basis of technology, the human microbiome research spending market is divided into cell culture technology, high-throughput technology, omics technology, and computational tools. The cell culture technology segment is expected to account for the largest share of the global human microbiome research spending technology market in 2016. The large share can be attributed to the increasing R&D initiatives in the field of human microbiome.

Europe is expected to account for the largest share of the global human microbiome market in 2022. The large share of this region can be attributed to its significant presence in the probiotics and prebiotics fields and the acceptance of these products by its population.

-:Major Industry Leaders:-

Enterome Bioscience (France), Yakult (Japan), DuPont (U.S.), Metabiomics Corporation (U.S.), ViThera Pharmaceuticals (U.S.), Second Genome Inc. (U.S.), MicroBiome Therapeutics LLC (U.S.), Vedanta BioSciences (U.S.), Osel, Inc. (U.S.), and Merck (U.S.) are the major players in the human microbiome market. Domination of the individual segments in this market will depend on the core competencies of different players.

Companies that launch products targeted at specific indications in the human microbiome market are likely to maintain their positions in this market.

Pfizer is one such company; it releases medicines and vaccines for specific indications. The firm also entered into an agreement with Second Genome for microbiome research in obesity and metabolic disorders.

Read More@ https://www.marketsandmarkets.com/PressReleases/human-microbiome.asp

Companies in the human microbiome market are majorly focusing on expanding and entering segments for new indications and technology. The key strategy is to expand market share through acquisitions and connect financially with firms having common values and goals. To gain maximum market share, companies have been aggressively signing agreements, collaborations, and partnerships with third-party vendors. Enterome Bioscience is one such company the company focuses on developing biomarkers, companion diagnostic kits, and therapeutic solutions.

Major players that adopted this strategy include Second Genome (U.S.), Enterome Bioscience (France), Vedanta Bioscience (U.S.), and Osel, Inc. (U.S.). In April 2016, Enterome entered an agreement with Vertex Pharmaceuticals Inc. (U.S.) to research, develop, and commercialize novel small molecule FimH antagonists, to be utilized in the treatment of inflammatory bowel diseases (IBD).

Companies in the Asia-Pacific regions are also entering the field of microbiome. Yakult Honsha Co., Ltd. is one such company which is engaged in manufacturing and marketing food and beverage products. The company operates through three business segments, namely, Food and Beverages, Pharmaceuticals, and Others. The Food and Beverages segment includes juices, soft drinks, and healthy foods. This segment also includes probiotic drinks that contain Lactobacillus casei, a bacterium which improves intestinal function and immunity.

#Human Microbiome Market #Human Microbiome #HumanMicrobiomeMarket #HumanMicrobiome

[jessicalgross-blog]

FRIENDS, be watching for YET ANOTHER brand-spanking-NEW PRODUCT that will be released while we are at Convention! Yes, ANOTHER one and I've heard that if you thought the 💫NEW SLIM💫 was amazing, you're going to be BLOWN AWAY by this! 🙀🙀🙀 I can't wait!⠀ ⠀ I'm starting a 💥#VIP💥list of people who want to be informed the MOMENT the #newproduct is announced AND the #NEWSlim becomes #available to the public. If you want on that list please comment below OR MESSAGE ME!!! (If you are a customer/ambassador under somebody else, let them know 😍)⠀ ⠀ 👉🏼Some of you can get it NOW! Just PM me!⠀ Google #Akkermansia ⠀ Google "Is A Hidden Fungus Making You Ill?⠀ Google the #HumanMicrobiome⠀ Yup....#Plexus is the real deal. 💯

#plexus #akkermansia #newslim #newproduct #humanmicrobiome #available #vip💥list

[fleetscience-blog]

Where do your #microbes come from? Find out in #ZooinYou! At the Fleet only until Sunday, May 8! 🔬✨ #FleetScience #HumanMicrobiome #Bioscience #ScienceForEveryone (at Reuben H. Fleet Science Center)

#zooinyou #fleetscience #bioscience #microbes #humanmicrobiome #scienceforeveryone

[bazilbee-blog]

Happy to announce to have accepted a position at #UICAHS as a #graduatestudent studying the #humanmicrobiome #wildfermentation #dreams #chasingdreams #microbes (at University of Illinois at Chicago)

#microbes #humanmicrobiome #dreams #wildfermentation #uicahs #chasingdreams #graduatestudent

[oxyorganisms]

Try it for yourself and see how different environmental factors can impact your microbiome.

#oxyorganisms #humanmicrobiome

[healthcare-industry-research]

Increasing Collaborations in Human Microbiome Research Create Great Growth Opportunities for Major Industry Leaders

Rising aging population, increasing incidences of lifestyle diseases, gradual demand for efficient and safe medication with no side effects, and treatment of diseases having a limited success rate are driving the growth of the global Human Microbiome Market. The market is an emerging market with abundant opportunities and is expected to flourish within five to seven years owing to a number of products currently under the clinical trial phase. In this report, the global market is divided into three major segments namely, application, disease, and product. Based on disease, the market is categorized into obesity, diabetes, autoimmune disorders, cancer, acute diarrhea, mental disorders, and other diseases such as cardiovascular diseases, other immune disorders (irritable bowel syndrome), metabolic syndrome (elevated blood lipids, high BP, and liver diseases), other mental disorders (bipolar disorders, schizophrenia, and drug metabolism), and atopic dermatitis. Acute diarrhea is expected to account for the largest share of the market in 2022. The human microbiome research spending market, by technology, is divided into cell culture technology, high-throughput technology, omics technology, and computational tools. The cell culture technology is the most widely-used technology in microbiome research, and is expected to account for the largest share of the human microbiome research spending market in 2016. The large share of this segment can be attributed to its usage in the in vitro model to reproduce in vivo conditions and to study host-microbial community interactions. Europe is expected to dominate the market with a share of in 2022. It is the prime market for microbiome companies due to the huge awareness and acceptance of microbiome-based products, rising incidences of chronic and lifestyle diseases, and high awareness of pharmacogenomics/personalized medicine in this region. In addition, major local companies have easy access to this market, which makes Europe the largest and most significant market for suppliers. Enterome Bioscience (France), Yakult (Japan), DuPont (U.S.), Metabiomics Corporation (U.S.), ViThera Pharmaceuticals (U.S.), Second Genome Inc. (U.S.), MicroBiome Therapeutics LLC (U.S.), Vedanta BioSciences (U.S.), Osel, Inc. (U.S.), and Merck (U.S.) are the major players in the human microbiome market. Domination of the individual segments in this market will depend on the core competencies of different players. Read More Detailed Information | Get the Sample Pages@ http://bit.ly/2tk6j6J Companies that launch products targeted at specific indications in the human microbiome market are likely to maintain their positions in this market. Pfizer is one such company; it releases medicines and vaccines for specific indications. The firm also entered into an agreement with Second Genome for microbiome research in obesity and metabolic disorders. Companies in the human microbiome market are majorly focusing on expanding and entering segments for new indications and technology. The key strategy is to expand market share through acquisitions and connect financially with firms having common values and goals. To gain maximum market share, companies have been aggressively signing agreements, collaborations, and partnerships with third-party vendors. Enterome Bioscience is one such company the company focuses on developing biomarkers, companion diagnostic kits, and therapeutic solutions. The company provides products and technologies in the emerging areas of disease management for human gut microbiome and drugs for the treatment of various microbiome-related diseases, such as inflammatory bowel disease, metabolic diseases, and related disorders. In-depth research into the human microbiome market revealed that agreements, partnerships, and collaborations were the key strategies adopted by major players to enter the microbiome business or expand their microbiome business units. Major players that adopted this strategy include Second Genome (U.S.), Enterome Bioscience (France), Vedanta Bioscience (U.S.), and Osel, Inc. (U.S.). In April 2016, Enterome entered an agreement with Vertex Pharmaceuticals Inc. (U.S.) to research, develop, and commercialize novel small molecule FimH antagonists, to be utilized in the treatment of inflammatory bowel diseases (IBD). Read More@ https://www.marketsandmarkets.com/Market-Reports/human-microbiome-market-37621904.html

#HumanMicrobiomeMarket #human microbiome market #Human Microbiome #HumanMicrobiome

[bodyofmicrobes]

Probably the most beautiful graphic of a virus I've seen. Works great as an intro to Carl Zimmer's post on the human virome.

#virus #virome #humanmicrobiome #carlzimmer